Pyott David E I's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Jun 26, 2024
- Accession no.
- 0001735276-24-000070
- Filed
- Jun 26, 2024
- Trade date
- Jun 24, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $7.16M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pyott David E ICIK 0001051578 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | Common Stock | MOption exerciseAcquired | +17,560 | $88.95 | +$1,561,962 | 17,696 | Direct | |
| Jun 24, 2024 | Common Stock | MOption exerciseAcquired | +7,420 | $70.20 | +$520,884 | 25,116 | Direct | |
| Jun 24, 2024 | Common Stock | MOption exerciseAcquired | +7,470 | $71.99 | +$537,765.3 | 32,586 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −17,560 | $220.00 | −$3,863,200 | 15,026 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −7,420 | $221.00 | −$1,639,820 | 7,606 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −7,470 | $222.00 | −$1,658,340 | 136 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | Common Stock | MOption exerciseDisposed | −7,420 | $0.00 | $0 | 3,830 | Direct | |
| Jun 24, 2024 | Common Stock | MOption exerciseDisposed | −7,470 | $0.00 | $0 | 3,780 | Direct | |
| Jun 24, 2024 | Common Stock | MOption exerciseDisposed | −17,560 | $0.00 | $0 | 7,440 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.